Filter News
Area of Research
- (-) Materials (24)
- Advanced Manufacturing (1)
- Biology and Environment (7)
- Clean Energy (12)
- Computer Science (1)
- Fusion and Fission (2)
- Isotopes (5)
- Materials Characterization (1)
- Materials Under Extremes (1)
- National Security (6)
- Neutron Science (2)
- Nuclear Science and Technology (1)
- Quantum information Science (1)
- Supercomputing (14)
News Type
News Topics
- (-) Cybersecurity (1)
- (-) Isotopes (4)
- (-) Materials Science (17)
- (-) Polymers (3)
- (-) Quantum Science (3)
- (-) Sustainable Energy (2)
- 3-D Printing/Advanced Manufacturing (6)
- Bioenergy (3)
- Biomedical (2)
- Buildings (1)
- Chemical Sciences (9)
- Climate Change (3)
- Composites (2)
- Computer Science (2)
- Coronavirus (1)
- Critical Materials (1)
- Decarbonization (3)
- Energy Storage (4)
- Environment (3)
- Fusion (1)
- Grid (1)
- Materials (24)
- Microscopy (6)
- Molten Salt (1)
- Nanotechnology (7)
- Net Zero (1)
- Neutron Science (6)
- Nuclear Energy (2)
- Partnerships (3)
- Physics (8)
- Quantum Computing (1)
- Renewable Energy (1)
- Transportation (1)
Media Contacts
Scientists at the Department of Energy’s Oak Ridge National Laboratory used neutrons, isotopes and simulations to “see” the atomic structure of a saturated solution and found evidence supporting one of two competing hypotheses about how ions come
Sergei Kalinin of the Department of Energy’s Oak Ridge National Laboratory knows that seeing something is not the same as understanding it. As director of ORNL’s Institute for Functional Imaging of Materials, he convenes experts in microscopy and computing to gain scientific insigh...
The materials inside a fusion reactor must withstand one of the most extreme environments in science, with temperatures in the thousands of degrees Celsius and a constant bombardment of neutron radiation and deuterium and tritium, isotopes of hydrogen, from the volatile plasma at th...
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.